Evidence map›Paper›PMID 34868231›Full record

ArticleFrontiers in genetics2021

Combination of Tumor Mutational Burden and Specific Gene Mutations Stratifies Outcome to Immunotherapy Across Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma.

Ying-Peng Peng, Rong Wang, Qiao-Dan Liu, Xi-Wei Xu, Wei Wei, Xiao-Tao Huang, Xiao-Mou Peng, Zhi-Gang Liu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ying-Peng PengThe Cancer Center of the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
Rong WangThe Cancer Center of the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
Qiao-Dan LiuThe Cancer Center of the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
Xi-Wei XuThe Cancer Center of the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
Wei WeiThe Cancer Center of the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
Xiao-Tao HuangThe Cancer Center of the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
Xiao-Mou PengCenter of Infectious Diseases, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, China.
Zhi-Gang LiuThe Cancer Center of the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
Sun Yat-sen University · CNFifth Affiliated Hospital of Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

gene mutationimmunotherapyrecurrent and metastatic head and neck squamous cell carcinomasurvival prognosistumor mutational burden

Identifiers

PMID34868231
PMCPMC8637214
OpenAlexW3214416460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.